Business | Tissuepathology.com

Agilent Completes Acquisition of Proscia

Erica Goodpaster — Thu, 05 Nov 2026 13:12:24 +0000

Agilent: Expands Agilent’s pathology portfolio and establishes a platform for scientific intelligence in tissue-based precision medicine Strengthens Agilent’s ability to support customers across clinical diagnostics, biopharma and life-sciences research SANTA CLARA, Calif., November 04, 2026 — Agilent Technologies Inc. (NYSE: A) today announced the successful completion of its previously announced acquisition of Proscia®, a leading […]

The post Agilent Completes Acquisition of Proscia first appeared on Tissuepathology.com.

Agilent to Acquire Proscia, Advancing AI-Enabled Digital Pathology and Scientific Intelligence

Erica Goodpaster — Tue, 13 Oct 2026 13:03:31 +0000

Proscia: Advances Agilent’s position as a leading pathology solutions provider, with a unique and differentiated combination of instruments, reagents, and software Acquisition seamlessly builds on Agilent’s pathology portfolio expansion efforts and widens strategic moat in high-growth market SANTA CLARA, Calif. and PHILADELPHIA – October 13, 2026 – Agilent Technologies Inc. (NYSE: A) today announced it […]

The post Agilent to Acquire Proscia, Advancing AI-Enabled Digital Pathology and Scientific Intelligence first appeared on Tissuepathology.com.

ViewsML Appoints Digital Pathology Executive Michael Rivers to Board of Directors

Erica Goodpaster — Wed, 30 Sep 2026 12:10:25 +0000

Rivers brings more than 20 years of experience commercializing diagnostic and digital pathology technologies to support ViewsML’s continued growth and innovation Vancouver, BC —September 29, 2026— ViewsML, a leader in AI-powered virtual biomarker staining, today announced the appointment of Michael Rivers to its Board of Directors. Rivers brings more than 20 years of experience leading […]

The post ViewsML Appoints Digital Pathology Executive Michael Rivers to Board of Directors first appeared on Tissuepathology.com.

Gestalt: Why Healthcare IT Staff Augmentation Is Replacing Traditional Hiring in 2026

Erica Goodpaster — Mon, 24 Aug 2026 12:37:51 +0000

From the Gestalt blog: Healthcare IT isn’t shrinking, it’s resetting. After the surge of pandemic-era hiring, many health systems are stepping back and asking a hard question: does more headcount actually make us more agile? In 2026, with tighter margins, AI initiatives accelerating, and cybersecurity demands rising, the answer often isn’t yes. Fixed labor costs can […]

The post Gestalt: Why Healthcare IT Staff Augmentation Is Replacing Traditional Hiring in 2026 first appeared on Tissuepathology.com.

Global Leader in Digital Pathology AI Healthcare — aetherAI (7803) Officially Lists on the Taiwan Innovation Board

Erica Goodpaster — Fri, 14 Aug 2026 18:53:56 +0000

aetherAI: Delivering Integrated Software-and-Hardware Consulting Solutions for the Global Digital Transformation of Pathology — Growth Momentum Poised to Accelerate aetherAI (7803), a global leader in digital pathology and AI healthcare solutions, officially began trading on the Taiwan Innovation Board on May 20 at an offering price of NT$23.12 per share. A listing ceremony and opening […]

The post Global Leader in Digital Pathology AI Healthcare — aetherAI (7803) Officially Lists on the Taiwan Innovation Board first appeared on Tissuepathology.com.

ASCO: Now and Then

Dr. Keith J. Kaplan — Thu, 11 Jun 2026 18:00:28 +0000

In medical school I drove a cab at night to make ends meet. I rented the medallion from a guy for $50 and kept the difference I made. The Army paid me $692 a month stipend on the Health Professions Scholarship and the studio apartment in downtown Chicago was $1000/month. I wasshort over $300 a […]

The post ASCO: Now and Then first appeared on Tissuepathology.com.